Glyoxal

WeylChem Upgrades French Glyoxal Plant

WeylChem is investing about €15 million to upgrade glyoxal production at its site in Lamotte, France. A new plant, which will increase capacity by approximately a third, is expected to start operating in early 2024.

Topics • Strategy

On Track and Ready for Growth

Top-Feature

Easyfairs Deutschland GmbH

API Manufacturing

Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

WeylChem International GmbH

Glyoxal

WeylChem Upgrades French Glyoxal Plant

On Track and Ready for Growth

Top-Feature

Leading the way. Driving results.

Driving Sustainability Through Collaboration

Leading Transformation

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Brenntag Downsizes Management Board, Retains Both Divisions

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Anchored in Sustainability

API Manufacturing

Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition